Widely Used Pills Recalled for Deadly Flaw, FDA Yet to Act

The AHA! Team — Mon, 07 Jul 2025 05:39:14 +0000

Patrick Tims via NaturalHealth365 – An alert has been issued cautioning consumers against using a popular potassium chloride pill. The pills were recalled after a potentially fatal flaw was discovered. However, the Food and Drug Administration (FDA) has yet to act. This lack of immediate oversight raises serious concerns about the regulatory framework to protect public health. With millions of lives potentially at risk, the issue demands urgent attention. Potentially deadly flaw in commonly used pills all consumers should know about Official records reveal that Glenmark Pharmaceuticals issued over half a dozen recalls for its potassium chloride pills. The pills fail to properly dissolve when contacting moisture, such as saliva and other water, in the human body. This failure to dissolve has the potential to lead to pain, hospitalization, and death. The shocking twist is that the FDA has dragged its feet on investigating the Glenmark Pharmaceuticals drug factory’s flawed operations. To date, there has been no government inspection of the drug factory. The FDA is aware that the pills have the potential to cause deadly potassium spikes, yet it refuses to take meaningful action. The pills were produced at a single factory in India. If our federal government were the watchdog it claims to be, it would have prevented Glenmark Pharmaceuticals from shipping pills produced at the Mumbai factory to the rest of the United States. Why the potassium chloride pills have the potential to kill healthy people There is a widespread misconception that potassium chloride is entirely safe simply because it has been on the market for decades. The drug is frequently prescribed to address issues with muscle and nerve function and is particularly valued for its benefits to heart health. While potassium chloride pills are effective for individuals with low potassium levels, they can pose significant risks under certain conditions. Excessive amounts of the drug can have lethal consequences. High doses of potassium chloride can result in complete heart failure, a risk that cannot be ignored. This danger is so pronounced that potassium chloride is a key component in lethal injections used for executions in several states. This reality highlights just how deadly the drug can be when misused or improperly formulated. Is a recall of the drug enough? The danger of Glenmark Pharmaceuticals’ potassium chloride pills became apparent in May when the Indian drugmaker recalled nearly 47 million capsules. The extended-release medication’s failure to dissolve prompted the FDA to issue its own recall of the defective product. Shockingly, the FDA was already aware of manufacturing issues at Glenmark Pharmaceuticals’ facilities at the time of the recall. Over the previous eight months, the Mumbai-based drugmaker had been responsible for four separate recalls. In the months following, two more recalls were issued, each citing the same critical flaw: the pills’ inability to dissolve properly. While recalls play a crucial role in protecting consumers, they are far from sufficient in addressing systemic issues. The FDA has failed to prevent Glenmark from continuing to distribute potentially dangerous pills to the American market. Even more troubling is the agency’s failure to thoroughly investigate the root cause of the problem. Despite the glaring risks, the FDA has not conducted an on-site inspection of Glenmark’s Mumbai facility since its last review – more than four years ago. This glaring oversight raises serious concerns about the FDA’s capacity to enforce meaningful accountability and ensure the safety of imported drugs. Glenmark Pharmaceuticals: A case study in corporate negligence It seems we have drifted too far toward a laissez-faire economy, where corporate greed often goes unchecked. Within a single year, Glenmark Pharmaceuticals issued seven recalls for medications that failed to dissolve as intended, yet no significant government action has been taken to address the underlying issues. Glenmark’s public relations team has acknowledged three deaths and several hospitalizations linked to their defective products. FDA records corroborate these reports, confirming the dangers of potassium chloride pills. However, the FDA appears reluctant to formally attribute these deaths and hospitalizations to the drug, allowing Glenmark’s pursuit of profit to continue virtually unimpeded. The time has come for a comprehensive overhaul of the FDA. The agency currently lacks the resources and authority to effectively oversee the manufacturing, distribution, and recall of generic medications produced in factories outside the United States. If the FDA were fulfilling its intended role, it would immediately take decisive action against Glenmark. Sources for this article include: IPDpharma.com Childrenshealthdefense.org To read the original article click here.

The post Widely Used Pills Recalled for Deadly Flaw, FDA Yet to Act appeared first on Amazing Health Advances.

Salt Substitute Is a Cost-Effective Intervention for Stroke Prevention and Improved Quality of Life

AHA Publisher — Wed, 27 Apr 2022 07:00:38 +0000

Northwestern University via News-Medical – A salt substitute that contains less sodium was a cost-effective intervention for prevention of stroke and improved quality of life, according to an analysis published in the journal Circulation. A previous study found the substitute was effective at preventing stroke and heart attack, so these findings further cement this intervention’s usefulness, according to Darwin Labarthe, MD, PhD, MPH, professor of Preventive Medicine in the Division of Epidemiology and a co-author of the study. “Because hypertension is so highly prevalent, and costs of its morbidity and mortality outcomes are so great, a cost-saving intervention has huge implications for national health expenditures.” Darwin Labarthe, MD, PhD, MPH, Professor of Preventive Medicine, Division of Epidemiology Reducing salt intake reduces blood pressure, which is a primary contributor to disease and death from heart attack or stroke. As many as one billion people around the world have uncontrolled high blood pressure, Labarthe said, and that number only continues to grow. Salt substitutes — in this study, a salt made of a mix of sodium chloride and potassium chloride — have been shown to reduce blood pressure. A previous study of more than 20,000 individuals in 600 villages in northwestern China found rates of stroke, major cardiovascular events and death were all lower in participants using salt substitutes when compared to participants using regular salt. In the current study, investigators performed a cost-effectiveness analysis of the previous study, measuring health outcomes in quality-adjusted life years (QALYs). Healthcare costs were identified from participant health insurance records and estimated using figures from previous studies. Over the nearly five-year follow-up period, replacing regular salt with salt substitute reduced the risk of stroke by 14 percent. The salt substitute group had on average 0.054 more QALYs per person. The average annual costs were lower in the salt-substitute group: 1,538 Chinese yuan (about $241) for the intervention group and 1,649 Chinese yuan (about $259) for the control group. This means the intervention was dominant — a term used in cost-effectiveness denoting better outcomes at lower cost — for prevention of stroke. Sensitivity analyses performed by the authors showed these conclusions held even when the price of salt substitutes was raised, only losing cost-effectiveness when the price was increased to the highest market prices identified in China. “This presents powerful ‘hard outcome’ evidence long demanded by sodium reduction skeptics who failed to see the value of interventions that would lower blood pressure itself, despite it being an immense health and public health problem,” Labarthe said. This intervention holds promise, especially in countries such as China where large segments of the population consume home-prepared rather than commercially with processed food, in contrast to Western countries such as the United States, according to Labarthe. “Governments and health systems would benefit and would serve their beneficiaries by implementing salt substitution as an important means to reduce blood pressure and risk of stroke,” Labarthe said. “This will be impactful to the degree that individual behavior determines how much salt is consumed; it will be less so where the processed or manufactured foods predominate, until the food industry adopts the use of salt substitute in its products.” To read the original article click here.

The post Salt Substitute Is a Cost-Effective Intervention for Stroke Prevention and Improved Quality of Life appeared first on Amazing Health Advances.

potassium chloride Archives - Amazing Health Advances

Widely Used Pills Recalled for Deadly Flaw, FDA Yet to Act

Salt Substitute Is a Cost-Effective Intervention for Stroke Prevention and Improved Quality of Life